Tuesday 29 March 2022

Reuters Global Healthcare: CDC recommends second COVID booster shot for some people

CDC recommends second COVID booster shot for some people

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday updated its recommendation to allow certain immunocompromised individuals and people over the age of 50 to receive an additional booster dose of COVID-19 vaccines.

FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans

The U.S. FDA cited data showing waning immunity and the risks posed by Omicron variants of the virus.

UK says healthcare workers, vulnerable will still get free COVID tests

Britain said on Tuesday that healthcare workers, social care staff and the most vulnerable will still get COVID-19 tests without any charge when it ends free testing for the general public next month.

France reports over 217,000 new COVID-19 infections - health ministry

France on Tuesday reported 217,480 new COVID-19 infections over the last 24 hours, a level unseen since early February.

U.S. FDA considering additional round of boosters in the fall -official

The U.S. Food and Drug Administration will weigh the benefits of authorizing a round of boosters of either the Pfizer/BioNTech or Moderna COVID-19 vaccine to a broader population in the fall, a top official said on Tuesday.

In China's Wall Street, bankers and traders sleep in offices to beat COVID lockdown

Shanghai started a lockdown by dividing the city roughly along the Huangpu River, to allow for staggered testing.

FDA authorizes second booster of Pfizer/BioNTech COVID shot

U.S. regulators authorized a second booster dose of Pfizer Inc and BioNTech SE's COVID-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday.

Tobacco has new role to play in cultivated meat production - Israeli biotech says

Israeli startup BioBetter is repurposing tobacco plants to produce ingredients that promote cell growth in a step that could remove one of the biggest obstacles to large-scale lab meat manufacturing.

Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. - CDC

The U.S. national public health agency said on Tuesday that BA.2 sub-variant of Omicron was estimated to account for more than half the coronavirus variants in the country.

EU starts real-time review of Hipra's COVID vaccine

Europe's drug regulator said on Tuesday it had started a real-time review of Spanish pharmaceutical firm Hipra's COVID-19 vaccine candidate.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study